Skip to main content

Increase in systolic blood pressure and improvement in laboratory parameters following polymyxin B-immobilized fiber treatment in septic shock

Introduction

Direct hemoperfusion using a polymyxin B-immobilized fiber column (DHP-PMX; Toray Industries Inc., Tokyo, Japan) was first developed in 1994 and has since been used for the treatment of septic shock.

Methods

A total of 47 patients with septic shock who received DHP-PMX for 2 to 6 hours were retrospectively reviewed to examine any improvement in sepsis-related factors after DHP-PMX and to analyze the relationship between any such improvement and increase in SBP. In addition, we analyzed the effectiveness of long-term DHP-PMX (5 to 6 hours) with respect to improvement in sepsis-related factors.

Results

N-arachidonoylethanolamine (AEA), 2-arachidonoyl glycerol (2-AG), and plasminogen activator inhibitor-1 (PAI-1) were significantly improved after DHP-PMX treatment. SBP increased significantly in the group showing improved high mobility group box protein 1 (HMGB-1) level (P < 0.0122). AEA, 2-AG and HMGB-1 were improved in all four patients who were treated with long-term DHP-PMX.

Conclusions

We observed a relationship between hemodynamic improvement and a decrease in serum HMGB-1 level in septic shock patients treated with DHP-PMX. We suggest that long-term DHP-PMX improves sepsis-related factors.

Figure 1
figure1

Changes in systolic blood pressure in patients treated with DHP-PMX in whom HMBG-1 level increased. P < 0.0001.

References

  1. 1.

    Sakamoto Y, et al: ASAIO J. 2007, 53: 646-650. 10.1097/MAT.0b013e3181492395.

    Article  Google Scholar 

Download references

Author information

Affiliations

Authors

Corresponding author

Correspondence to Y Sakamoto.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Sakamoto, Y., Mashiko, K., Obata, T. et al. Increase in systolic blood pressure and improvement in laboratory parameters following polymyxin B-immobilized fiber treatment in septic shock. Crit Care 14, P73 (2010). https://doi.org/10.1186/cc8305

Download citation

Keywords

  • Septic Shock
  • High Mobility Group
  • Septic Shock Patient
  • Fiber Treatment
  • Hemodynamic Improvement